Skip to main content

Table 1 Clinicopathologic characteristics of the patients with HCC

From: TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A

Parameters Total number of the patients (N = 87)
Age (years)
 ≤53 47 (54.0%)
 > 53 40 (46.0%)
Sex
 Female 8 (9.2%)
 Male 79 (90.8%)
Tumor size (cm)
 ≤4 25 (28.7%)
 > 4 62 (71.3%)
Recurrence (2 years)
 Yes 63 (72.4%)
 No 24 (27.6%)
Differentiation
 Low 39 (44.8%)
 Moderate 38 (43.7%)
 High 10 (11.5%)
Tumor number
 Single 64 (73.6%)
 Multiple 23 (26.4%)
TNM stages
 I 15 (17.2%)
 II 22 (25.3%)
 III 20 (23.0%)
 IV 30 (34.5%)
Pathologic stages
 I 6 (6.9%)
 II 34 (39.1%)
 III 40 (46.0%)
 IV 7 (8.0%)
Lung metastasis
 Yes
 No
16 (18.4%)
71 (81.6%)
HBsAg
 Negative 7 (8.0%)
 Positive 80 (92.0%)
HBV infection
 Absent 7 (8.0%)
 Present 80 (92.0%)
  1. HBsAg: hepatitis B surface antigen; HBV: hepatitis B virus